The suggested ULN for ALT has generally been ≤35 for men and ≤26 for women, when defined using healthy populations with low risk for NAFLD and normal BMI, triglyceride and glucose concentrations [5,15,16,17]. The gene discussed is GPT; the disease is metabolic dysfunction-associated steatotic liver disease.